Skip to content
Menu
Qualify for a Medical Study for Rheumatoid Arthritis
Treatment
About
FAQ
Learn More
Close Menu
This browser does not support inline PDFs. Please download the PDF to view it:
Download PDF
Biologic and targeted synthetic DMARDs include:
Abatacept (Orencia)
Adalimumab (Humira)
Anakinra (Kineret)
Baricitinib (Olumiant)
Certolizumab (Cimzia)
Etanercept (Enbrel)
Golimumab (Simponi)
Infliximab (Remicade)
Rituximab (Rituxan, MabThera)
Sarilumab (Kevzara)
Tocilizumab (Actemra)
Tofacitiniib (Xeljanz, Xeljanz XR)
Upadacitinib (Rinvoq)
Conventional synthetic DMARDs include:
Hydroxychloroquine (Plaquenil)
Leflunomide (Arava)
Methotrexate (Rheumatrex, Trexall, Otrexup, Rasuvo)
Sulfasalazine (Azulfidine)
